Role of salt in the control of blood pressure in obesity and diabetes mellitus

Hypertension

Volumn 17, Issue 1, 1991, Pages

  Tuck, Michael L ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood pressure regulation; Diabetes; Obesity; Salt

Indexed keywords

SODIUM CHLORIDE;

BLOOD PRESSURE; CONFERENCE PAPER; DIABETES MELLITUS; DRUG EFFECT; HUMAN; META ANALYSIS; OBESITY; PRIORITY JOURNAL; ROLE PLAYING;

BLOOD PRESSURE; DIABETES MELLITUS; HUMAN; HYPERTENSION; OBESITY; SODIUM CHLORIDE;

EID: 0025979286     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.17.1_suppl.i135     Document Type: Article

References (104)

1. Ferrannini E, DeFronzo RA: The association of hypertension diabetes and obesity: A review. J Nephrol 1989;1:3–15
2. Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM: Relation of adiposity to blood pressure and development of hypertension: The Framingham Study. Ann Intern Med 1967;67:48–59
3. Stamler R, Stamler J, Riedlinger WF, Algera G, Roberts RJ: Weight and blood pressure: Findings in hypertension screening of one million Americans. JAMA 1978;240:1607–1610
4. Bcrglund G, Larsson B, Andersson O: Body composition and glucose metabolism in hypertensive middle-aged males. Acta Med Scand 1976;200:163–169
5. Ruderman NB, Schneider SH, Berchtold P: The "metabolically obese” normal-weight individual. Am J din Nutr 1981; 34:1617–1622
6. Reisin E: Sodium and obesity in the pathogenesis of hypertension, Am J Hypertens 1990;3:164–167
7. Dustan HP, Tarazi RC, Mujais S: A comparison of hemodynamic and volume characteristics of obese and nonobese hypertensive patients. Ini J Obei 1981;5:19–25
8. Messerli FH, Sundgaard-Riise K, Reisin E: Disparate cardiovascular effects of obesity and arterial hypertension. Am J Med 1983;74:808–812
9. Mujais SK, Tarazi RC, Dustan HP, Fouad FM, Bravo EL: Hypertension in obese patients: Hemodynamic, intravascular volume studies. Hypertension 1982;4:84–92
10. Tuck ML, Sowers J, Domfetd L, Kledzik G, Maxwell M: The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients. N Engl J Med 1981;304:930–933
11. Reisin E, Frohlich ED, Messerli FH: Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983;98:315–319
12. James WP, Haraldsdoltir J, Liddell F, Jung RT, Shetty PS; Autonomic responsiveness in obesity with and without hypertension. Am J Obes 1981,5:73–78
13. Kreiger DR, Landsberg L: Mechanisms in obesity-related hypertension: Role of insulin and catecholamines. Am J Hypertens 1988;1:84–90
14. Sowers JR, Nyby M, Stem N, Beck FWJ, Baron S, Catania R: Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982;4:686–691
15. Tuck ML, Sowers JR, Domfeld L, Whitfield L, Maxwell M: Reductions in plasma catecholamines and blood pressure during weight loss in obese subjects. Acta Endocrinol (Copenh) 1983; 102:252–257
16. Schwartz RS, Halter JB, Bierman EL: Reduced thermic effect of feeding in obesity: Role of norepinephrine. Metabolism 1983;32:114–117
17. Peterson HR, Rothchild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA: Body fat and the activity of the autonomic nervous system. N Engl J Med 1988;318:1077–1083
18. Domfeld LP, Maxwell MH, Waks A, Tuck ML: Mechanisms of hypertension in obesity. Kidney Int 1987;22:s254-s258
19. Dahl LK, Silver L, Christie RW: The role of salt in the fall of blood pressure accompanying reduction in obesity. N Engl J Med 1958;258:1186–1192
20. Reisin E, Abel R, Modan M, Silverberg DS, Eliahou HE, Modan B: Effects of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1987;298:1–6
21. Eliahou HE, Iaina A, Gaon T: Body weight reduction necessary to attain normotension in the overweight hypertensive patient. Int J Obes 1981;5:157–163
22. Rocchini AP, Katch V, Schork A, Kelch RP: Insulin and blood pressure during weight loss in obese adolescents. Hypertension 1987;10:267–273
23. Rocchini AF, Katch V, Anderson J, Henderliter J, Becque D, Martin M, Marks C: Blood pressure in obese adolescents: The effect of weight loss. Pediatrics 1988;82:16–24
24. Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M; The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989;321:580–585
25. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, BeviJacqua S: Insulin resistance in essential hypertension. N Engl J Med 1987;317:350–357
26. Welbom TA, Breckenridge A, Rubenstein AH, Dollery CT, Fraser TR: Serum-insulin in essential hypertension and peripheral vascular disease. Lancet 1966;1:1336–1337
27. Jarretl RJ, Keen H, McCartney M: Glucose tolerance and blood pressure in two population samples: Their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978;7:15–24
28. Lucas CP, Estigarribia JA, Darga LL, Reaven GM: Insulin and blood pressure in obesity. Hypertension 1985;7:702–706
29. Manicardi V, Camellini L, Bellodi G, Coscelli C, Ferrannini E: Evidence for an association of high blood pressure and hyper-insulinemia in obese man. I Clin Endocrinol Metab 1986;62:1302–1304
30. Rose HG, Yalow RS, Schweitzer P, Schwartz E: Insulin as a potential factor influencing blood pressure in amputees. Hypertension 1986;8:793–800
31. Bjornlorp P: Hypertension and exercise. Hypertension 1982; 4(suppl 3):56–59
32. Hiramaisu K, Yamada T, Ichikawa K, Izumiyama T, Nagata H: Changes in endocrine activities relative to obesity in patients with essential hypertension. J Am GeriatrSoc 1981; 29:25–30
33. Rocchini AP, Katch VL, Grekin R, Moorehead C, Anderson J: Role for aldosterone in blood pressure regulation of obese adolescents. Am J Cardiol 1986;57:613–618
34. Vierhapper H, Waldhausl W, Nowotny P: The effect of insulin on the rise in blood pressure and plasma aldosterone after angiotensin II in normal man. Clin Sci 1983;64:383–386
35. Lin MH, Romsos DR, Akera T, Leveille GA. Na+-K+-ATPase enzyme units in skeletal muscle from lean and obese mice. Biochem Biophys Res Common 1978;80:398–404
36. DeLuise M, Blackburn GL, Flier JS: Reduced activity of the red-cell sodium-potassium pump in human obesity. N Engl J Med 1980;303:1017–1022
37. Sowers JR, Whitfield L, Beck FWH, Tuck ML, Dornfeld L, Maxwell M: Role of enhanced sympathetic nervous system activity and reduced Na+-K+-dependent adenosine triphosphatase activity in maintenance of elevated blood pressure in obesity. Clin Set 1982;3:121–124
38. Klimes I, Nagulesparan M, Unger RH, Aronoff SL, Mon DM: Reduced Na+-K+-ATPase activity in intact red cells and isolated membranes from obese man. J Clin Endocrinol 1982; 54:721–724
39. Simonson DC: Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 1988;11:821–827
40. Stem N, Tuck ML: Mechanisms of hypertension in diabetes mellilus, in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis and Management. New York, Raven Press, Publishers, 1990, pp 1689–1702
41. Sowers JR, Levy J, Zemel M: Hypertension and diabetes, Med Clin North Am 1988;72:1399–1414
42. Christlieb AR: Treatment selection considerations for the hypertensive diabetic patient. Arch Intern Med 1990;150:1167–1174
43. Christlieb AR: The hypertension of diabetes. Diabetes Care 1982;5:50–58
44. DeChatel R, Weidmann P, Flammer J, et al: Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int 1977;12:412–421
45. Weidmann P, Beretta-Piccoli C, Keusch G, Gluck Z, Mujagic M, Grimm M, Meier A, Ziegler W: Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 1979;67:779–784
46. Beretta-Piccoli C, Weidmann P, Ziegler W, Glide Z, Keusch G: Plasma catecholamines and renin in diabetes mellitus. Klin Wochenschr 1974;57:681–691
47. O’Hare JA, Ferriss JB, Twomey BM, Gonggrijp H, O’Sullivan DJ: Changes in blood pressure, body fluids, circulating angiotensin II and aldosterone with improved diabetic control. Clin Sci 1982;63:415s-418s
48. O’Hare JA, Brady D, Ferris JB, Twomey BM, O’Sullivan DJ: Total exchangeable sodium and blood pressure in diabetes. Dtabetologia 1982;23:472
49. Beretta-Piccoli C, Weidmann P: Body sodium-volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab 1982;7:36–47
50. Beretta-Piccoli C, Weidmann P, Fraser R: Responsiveness of plasma 18-hydtoxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus. Diabetes 1983;32:1–5
51. O’Hare JA, Minaker K, Young JB: Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men. Clin Res 1985;33:441
52. Beretta-Piccoli C, Weidmann P: Exaggerated pressor responsiveness to norepinephrine in non-azotemic diabetes mellitus. Am J Med 1981;71:829–835
53. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bennet-Hansen L, Nielson MD: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type I (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:610–617
54. Perez GO, Lespier L, Jacobi J: Hyporeninemia and hypoaldosteronism in diabetes mellilus. Arch Intern Med 1977; 137:852–855
55. Ferriss JB, Sullivan PA, Gonggrijp H, Cole M, O’Sullivan DJ: Plasma angiotensin II and aldosterone in unselected diabetic patients. Clin Endocrinol (Oxf) 1982;17:261–269
56. Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z: Hyper-insulinemia: A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75:809–817
57. Reaven CM: Role of insulin resistance in human disease. Diabetes 1988;37:1595–1606
58. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988;37:303–305
59. Kurtz TW, Morris RC, Pershadsingh HA; The Zucker fatty rat as a genetic model of obesity and hypertension. Hypertension 1989;13:896–901
60. Hwang I, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987;10:512–516
61. Miller JH, Bogdonoff MD: Antidiuresis associated with administration of insulin. J Appl Physiol 1954;6:509–512
62. Kolanowski J: Influence of insulin and glucagon on sodium balance in obese subjects during fasting and refeeding. Int J Obes 1981;5(suppl 1):105–114
63. DeFronzo RA: Insulin and renal sodium handling: Gimcal implications. Int J Obes 1981;5(suppl 1):93–104
64. Kolanowski J, DeGasparo M, Desmecht P, Crabbe J: Further evaluation of the role of insulin in sodium retention associated with carbohydrate administration after a fast in the obese. Ear J Clin Invest 1972;2:439–444
65. Rebello T, Hodges RE, Smith JL: Short-term effects of various sugars on antinatriuresis and blood pressure changes in normotensive young men. Am J Clin Nutr 1983;38:84–94
66. Tedde R, Sechi LA, Marigliano A: Anti natriuretic effect of insulin: A clinical experience in diabetic hypertensive patients with exogenous hyper-insulinemia. Am J Hypertens 1989;2:163–170
67. Izumi I, Honda M, Tsuchiya M: Effect of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension. Endocrinol Jpn 1980;2:505–511
68. Thorbum AW, Brand JC, Stewart Truswell A: Sail and glycaemic response. Br Med J [Gin Res] 1986;292:1967–1969
69. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PH: The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest 1975;55:845–855
70. DeFronzo RA, Goldberg M, Agus Z: The effects of glucose and insulin on renal electrolyte transport, J Clin Invest 1976;58:83–90
71. Nizet A, Lefebvre P, Crabbe J: Control by insulin of sodium, potassium and water excretion by the isolated dog kidney. Pflugers Arch 1971;323:11–20
72. Baum M: Insulin stimulates volume absorption in the rabbit proximal convoluted tubule. J Clin Invest 1987;79:1104–1109
73. Fidelman ML, May JM, Biber TUL, Watlington CO: Insulin stimulation of Na+ transport and glucose metabolism in cultured kidney cells. Am J Physiol 1982;242:C121–C123
74. Andres R, Crabbe J: Stimulation by insulin of active sodium transport by toad skin: Influence of aldosterone and vasopressin. Arch Int Physiol Biochim 1966;75:538–540
75. Cox M, Singer I: Insulin mediated Na+ transport in the toad urinary bladder. Am J Physiol 1977;232:270–277
76. Rowe JW, Young JB, Minaker KL, Stevens AL, Palkma J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous activity. Diabetes 1981;30:219–225
77. Christensen NJ, Gundersen HJG, Hegedus L: Acute effects of insulin on plasma noradrenaline and the cardiovascular system. Metabolism 1980;29:1138–1145
78. Cryer PE: Physiology and pathophysiology of the human sympathoadrenal system. N Engl J Med 1980;303:436–443
79. Barney FR; Abnormal vascular reaction in diabetes mellitus. Acta Med Scand 1955;304(suppl):152–155
80. Christlieb AR, Janka HU, Kraus B: Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects. Diabetes 1976;25:268–274
81. Weidmann P, Beretta-Piccoli C, Trost BN: Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985;7(suppl II):II-1133–II-1142
82. Drury PL, Smith GM, Ferriss JB: Increased vasopressor responsiveness to angiotensin II in type I (insulin-dependent) diabetic patients without complications. Diabetologia 1984; 27:174–179
83. Trujillo A, Tuck ML, Eggena P, Barret J, Stern N: Salt sensitivity and vascular reactivity in hypertensive diabetics on high and low sodium intake (abstract). Proceedings of the Second Annual Meeting of the American Society of Hypertension, 1987, p 26
84. Tuck ML, Cony DB, Trujillo A: Salt sensitive blood pressure and exaggerated vascular reactivity in the hypertension of diabetes mellitus. Am J Med 1990;88:210–216
85. O’Hare JP, Roland JM, Walters G, Corrall RJM: Impaired sodium excretion in response to volume expansion induced by water immersion in insulin-dependent diabetes mellitus. Clin Sci 1986;71:403–409
86. McQuame I, Thompson WH, Anderson JA: Effects of excessive sodium and potassium salts on carbohydrate metabolism and blood pressure in diabetic children. J Nutr 1936; 11:77–101
87. Faris I, Agerskov K, Henrikenson O: Decreased distensibility of a passive vascular bed in diabetes mellitus: An indicator of microangiopathy. Diabetoiogia 1982;23:411–414
88. Alexander WD, Oake RJ: The effect of insulin on vascular reactivity to norepinephrine. Diabetes 1977;26:611–614
89. Yagi S, Takata S, Kiyokawa H: Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein. Diabetes 1988;37:1064–1067
90. Stout R: Overview of the association between insulin and atherosclerosis. Metabolism 1985;34(suppl 1):7–12
91. Stolar MW: Atherosclerosis in diabetes: The role of hyper-insulinemia. Metabolism 1988;37(suppl 1):1–9
92. Weder AB: Red cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 1986; 314:198–201
93. Canessa M, Adragna N, Solomon HS, Connolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension, N Engl J Med 1980;302:772–776
94. Williams RR, Hunt SC, Kuida H, Smith JB, Ash KO: Sodium-lithium countertransport in erythrocytes of hypertension prone families in Utah. Am J Epidemiol 1983;118:338–344
95. Mangili R, Bending JJ, Scott G, Li LK, Gupta A, Viberti GC: Increased sodium-lithium countertransport activity in red cells of patients with insulin-dependent diabetes and nephropathy. N Engl J Med 1988;318:146–150
96. Krolewski AS, Canessa M, Warram J, Laffel LMB, Christlieb R, Knowler WC, Rand LI; Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988;381:140–145
97. Moore RD: Stimulation of Na:H exchange by insulin, Bio phys J 1981;33:203–210
98. Belfiore P, Iannello S, Vaglioni G: Regulation of sodium-potassium activated adenosine triphosphatase (Na-K-ATPase) by insulin: Relevance to diabetes and obesity. Diabetes 1982;31:1017–1022
99. Putnam RW; Effect of insulin on intracellular pH in frog skeletal muscle fibers. Am J Physiol 1985;248:C330-C336
100. Livne A, Veitch R, Grinstein S, Balfe JW, Marquez-Julio A, Rolhstein A: Increased platelet Na+- H+ exchange rates in essential hypertension: Application of a novel test. Lancet 1987;1:533–536
101. Lucas PA, Lacour B, Comte L, Drueke T: Pathogenesis of abnormal acid-base balance in the young spontaneously hypertensive rat. Clin Sci 1988;75:29–34
102. Moolenaar WH: Effects of growth factors on intracellular pH regulation. Anna Rev Physiol 1986;48:363–376
103. Ortola FV, Ballerman BJ, Anderson S, Mendez RE, Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats: Potential mediator of hyperfiltration. J Clin Invest 1987;80:670–674
104. Mogensen CE: Glomerular filtration rate and renal plasma flow in short-term and long-term juvenile diabetes mellitus. Scand J Clin Lab Invest 1971;28:91–100